Trial intelligence / Profile preview

Optimization of bowel preparation for sigmoidoscopy: Moviprep versus bisacodyl/enema

2009-011248-21Phase 4Active

Start
Jul 2009
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of macrogol in None (2 arms). Primary endpoint: Adequately cleaned bowels for sigmoidoscopy. Started Jul 2009; status: active.

02

Drugs

macrogol

Beyond the preview

Go deeper on 2009-011248-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011248-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call